ICON plc | Clinical Research Organisation (CRO) for Drug Development

Ensuring scientific rigor in external control arms

Methodologies to support HTA decision making

Natural history studies to improve drug development in rare diseases

Rare disease drug development is challenging due to limited info on patient distribution, change in disease progression and relevant outcomes to define treatment benefits.

Practical considerations for decentralised & hybrid clinical trials

Making the transition.

Unlocking the potential of advanced therapies developed for rare diseases

How to leverage regulatory strategies and interactions with the EU EMA and the U.S. FDA to accelerate development

Featured Services

Seeking parallel consultation from regulators and HTA bodies in Europe

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.�

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

19 May 2022

Irritable Bowel Disease (IBD): A patient’s perspective

Finding appreciation in the experience and treatment of IBD as a life-changing condition.

17 May 2022

My Clinical Research story – Jeslyne Margrette Isaac

ICON's Jeslyne Margrette Isaac shares their personal experience with clinical trials.

14 May 2022

My Clinical Research story – Lisa Linn

ICON's Lisa Linn shares their personal experience with clinical trials.

14 May 2022

My Clinical Research story – Jill Doherty

ICON's Jill Doherty shares their personal experience with clinical trials.

13 May 2022

My Clinical Research story – Ellen Dalbo

ICON's Ellen Dalbo shares their personal experience with clinical trials.

13 May 2022

Clinical Trials Day – Employee Testimonials

ICON's Ben Prabhu, Amber Hallenborg, Shannon Jonietz, Rebekah Nolan, Kim Pope, Agustina Mazza, Linsey Barone, Catherine Bliss, Robyn Vancil, and Louisa Roberts share their personal experience with clinical trials.

11 May 2022

How joint venture models can boost Japan’s pharmaceutical industry

Japan is the third-largest consumer of ethical drugs and the world’s third-largest economy; therefore, it is an important development centre for new medicines. However, there are various cultural and economic challenges in Japan that make it difficult to manage a fixed workforce against a variable portfolio of clinical research.

27 April 2022

NICE guidance on real-world evidence to usher innovative treatments

NICE published new guidance to give patients early access to innovative treatments by allowing greater flexibility considering a broader evidence base, making it easier for innovative and promising treatments to reach the patient incorporating the usage of real-world evidence.

21 March 2022

Sharing my Down syndrome story - Beverly Romero

Beverly Romero tells the story of her son Oliver.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Healthcare Intelligence

Mainstreaming Cell & Gene Therapies

The evolution of FSP: not just for large pharma

Best practices to increase engagement with medical and scientific poster content